美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
69097-391-02	69097-391	HUMAN PRESCRIPTION DRUG	deferasirox	deferasirox	TABLET, COATED	ORAL	20200213	N/A	ANDA	ANDA211852	Cipla USA Inc.	DEFERASIROX	90 mg/1	30 TABLET, COATED in 1 BOTTLE (69097-391-02)
69097-391-20	69097-391	HUMAN PRESCRIPTION DRUG	deferasirox	deferasirox	TABLET, COATED	ORAL	20200213	N/A	ANDA	ANDA211852	Cipla USA Inc.	DEFERASIROX	90 mg/1	5 BLISTER PACK in 1 CARTON (69097-391-20) / 10 TABLET, COATED in 1 BLISTER PACK (69097-391-19)
69097-392-02	69097-392	HUMAN PRESCRIPTION DRUG	deferasirox	deferasirox	TABLET, COATED	ORAL	20200614	N/A	ANDA	ANDA211852	Cipla USA Inc.	DEFERASIROX	180 mg/1	30 TABLET, COATED in 1 BOTTLE (69097-392-02)
69097-392-20	69097-392	HUMAN PRESCRIPTION DRUG	deferasirox	deferasirox	TABLET, COATED	ORAL	20200614	N/A	ANDA	ANDA211852	Cipla USA Inc.	DEFERASIROX	180 mg/1	5 BLISTER PACK in 1 CARTON (69097-392-20) / 10 TABLET, COATED in 1 BLISTER PACK (69097-392-19)
69097-393-02	69097-393	HUMAN PRESCRIPTION DRUG	deferasirox	deferasirox	TABLET, COATED	ORAL	20200213	N/A	ANDA	ANDA211852	Cipla USA Inc.	DEFERASIROX	360 mg/1	30 TABLET, COATED in 1 BOTTLE (69097-393-02)
69097-393-20	69097-393	HUMAN PRESCRIPTION DRUG	deferasirox	deferasirox	TABLET, COATED	ORAL	20200213	N/A	ANDA	ANDA211852	Cipla USA Inc.	DEFERASIROX	360 mg/1	5 BLISTER PACK in 1 CARTON (69097-393-20) / 10 TABLET, COATED in 1 BLISTER PACK (69097-393-19)